T&L Co Ltd
KOSDAQ:340570
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
T&L Co Ltd
Common Stock
T&L Co Ltd
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Common Stock
₩4.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Common Stock
₩6.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
SD Biosensor Inc
KRX:137310
|
Common Stock
₩62.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Common Stock
₩29.1B
|
CAGR 3-Years
60%
|
CAGR 5-Years
56%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Common Stock
₩66.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Common Stock
₩6.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
|
T&L Co Ltd
Glance View
T&L Co., Ltd. develops medical polymer material products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2020-11-20. The firm's main products include wound treatment materials, orthopedic fixing materials, structural adhesives, and water repellents. The wound treatment materials include products such as hydrocolloids, foams, and hydrogels as wetting dressing agents necessary for wound healing. The orthopedic fixture materials include medical devices used for the treatment and correction of fractures such as casts and splints. The firm sells its products in domestic and overseas markets such as the United States, Germany, China, and Dubai.
See Also
What is T&L Co Ltd's Common Stock?
Common Stock
4.5B
KRW
Based on the financial report for Dec 31, 2024, T&L Co Ltd's Common Stock amounts to 4.5B KRW.
What is T&L Co Ltd's Common Stock growth rate?
Common Stock CAGR 5Y
17%
Over the last year, the Common Stock growth was 0%.
